Fund HoldingsSarissa Capital Management LP

Total Portfolio Value
$154.71M
Total Bought
$4.12M
Total Sold
$114.84M
Net Transaction
-$110.72M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
LANTHEUS HLDGS INC(LNTH)63,000100,000+37,0005,6369,7606.31%+4,124
VOR BIOPHARMA INC(VOR)618,000508,016-109,9846863650.24%-321
AMARIN CORP PLC24,850,62324,850,623012,05311,1367.20%-917
NEUROCRINE BIOSCIENCES INC(NBIX)309,116309,116042,19434,18822.10%-8,006
CYTOKINETICS INC(CYTK)833,799600,000-233,79939,22224,11415.59%-15,108
GILEAD SCIENCES INC(GILD)262,0800-262,08024,2080-24,208
IRONWOOD PHARMACEUTICALS INC16,390,00016,390,000072,60824,09315.57%-48,514
INNOVIVA INC(INVA)7,277,0002,816,022-4,460,978126,25651,05433.00%-75,201
Page 1 of 1